Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Lung cancer, Non small cell lung cancer (NSCLC), Secondary cancers
Closed
Phase 1/2
This study is looking at a type of immunotherapy called ATL001 for non small cell lung cancer (NSCLC).
It is open to people with non small cell lung cancer that has either:
spread into the nearby tissue (locally advanced) and cannot be removed by surgery
spread to another part of the body (metastatic)
Recruitment start: 8 July 2019
Recruitment end: 26 September 2024
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Martin Forster
Achilles Therapeutics
Last reviewed: 22 Oct 2024
CRUK internal database number: 18281
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
